DUPILUMAB IMPROVED SINONASAL AND ASTHMA OUTCOMES VERSUS OMALIZUMAB IN PATIENTS WITH SEVERE CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP) AND COEXISTING ASTHMA: RESULTS FROM A PROSPECTIVE, RANDOMISED, HEAD-TO-HEAD PHASE 4 TRIAL (EVEREST)